Alcon and Bausch + Lomb Each Release New Treatment Options for Postoperative Pain and Inflammation

At the Hawaiian Eye meeting in Waikoloa, Hawaii, Alcon Laboratories, Inc., and Bausch + Lomb separately announced the US release of treatments for pain and inflammation following cataract surgery. Alcon launched Ilevro (nepafenac ophthalmic suspension 0.3%), a once-daily nonsteroidal anti-inflammatory drug for the t...